202 related articles for article (PubMed ID: 1313893)
1. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines.
Guilhot S; Fowler P; Portillo G; Margolskee RF; Ferrari C; Bertoletti A; Chisari FV
J Virol; 1992 May; 66(5):2670-8. PubMed ID: 1313893
[TBL] [Abstract][Full Text] [Related]
2. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.
Bertoletti A; Ferrari C; Fiaccadori F; Penna A; Margolskee R; Schlicht HJ; Fowler P; Guilhot S; Chisari FV
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10445-9. PubMed ID: 1660137
[TBL] [Abstract][Full Text] [Related]
3. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
4. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.
Löhr HF; Gerken G; Schlicht HJ; Meryer zum Büschenfelde KH; Fleischer B
J Infect Dis; 1993 Nov; 168(5):1133-9. PubMed ID: 8228346
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
Rehermann B; Fowler P; Sidney J; Person J; Redeker A; Brown M; Moss B; Sette A; Chisari FV
J Exp Med; 1995 Mar; 181(3):1047-58. PubMed ID: 7532675
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B.
Ito Y; Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Koike K
Gastroenterol Jpn; 1993 Oct; 28(5):657-65. PubMed ID: 7693538
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus-DNA transfected myeloma cell-specific cytotoxic T cells in chronic hepatitis B patients.
Kamogawa Y; Yamauchi K; Obata H; Chisaka O; Matsubara K
Virology; 1992 Nov; 191(1):321-6. PubMed ID: 1413509
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens.
Penna A; Fowler P; Bertoletti A; Guilhot S; Moss B; Margolskee RF; Cavalli A; Valli A; Fiaccadori F; Chisari FV
J Virol; 1992 Feb; 66(2):1193-8. PubMed ID: 1731098
[TBL] [Abstract][Full Text] [Related]
9. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-specific cytotoxic T lymphocyte responses in patients with acute and chronic hepatitis B virus infection.
Van Hecke E; Paradijs J; Molitor C; Bastin C; Pala P; Slaoui M; Leroux-Roels G
J Hepatol; 1994 Apr; 20(4):514-23. PubMed ID: 8051391
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.
Chisari FV
Curr Top Microbiol Immunol; 1996; 206():149-73. PubMed ID: 8608715
[TBL] [Abstract][Full Text] [Related]
12. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses.
Roh S; Lee YK; Ahn BY; Kim K; Moon A
Virus Res; 2001 Jan; 73(1):17-26. PubMed ID: 11163641
[TBL] [Abstract][Full Text] [Related]
13. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus immunopathogenesis.
Chisari FV; Ferrari C
Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813
[TBL] [Abstract][Full Text] [Related]
17. T cell recognition of hepatitis B and C viral antigens.
Jung MC; Diepolder HM; Pape GR
Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
[TBL] [Abstract][Full Text] [Related]
18. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
19. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
Lei CL; Huang CH; Yang Z; Tang XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
[TBL] [Abstract][Full Text] [Related]
20. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
